MK-677 159752-10-0

Min.Order / FOB Price:Get Latest Price

1 Kilogram	FOB Price:USD 15.0000 -50.0000

1 Kilogram

FOB Price:USD 15.0000 -50.0000

Min.Order :1 Kilogram
Purity: >99%
Payment Terms : L/C,D/A,D/P,T/T

Keywords

CRESCENDO Ibutamoren mesylate MK 0677

Quick Details

Appearance:powder
Application:Used as an intermediate in the drug telmisartan
PackAge:5mg/vial, 10 vials per box
ProductionCapacity:3000|Kilogram|Month
Storage:2-8°C
Transportation:EMS,DHL,?TNT,?UPS?,FEDEX,?BY?AIR,?BY?SEA DHL?Express,?FedEx?and?EMS?for?quantity?less?than?50KG,?usually?called?as?DDU?service;? Sea?shipping?for?quantity?over?500KG;?And?air?shipping?is?available

Superiority:

Our Advantage

Rich Experience
Our products are sold all over Europe,North&South America, Sino-East, Asia and pacific area as well as Africa,we establish long term.

Quality service
Company cooperates with research institutes. We strictly control the process of raw materials up to finished product.

24 hour service
Quick and clear response to customers questions. Warm after sale service, we will help to solve the problems in your usage.

High quality
Dedicated to serving customers first, we provide reasonable prices, high quality products.

Details:

Molecular Formula	C28H40N4O8S2
Molar Mass	624.77
Melting Point	164-170°C
Solubility	10 mM in DMSO
Appearance	powder
Color	white to beige
Storage Condition	2-8°C
Use	Ibrutam mesylate is a drug that acts as a potent, orally effective somatotropin secretion, mimicking the action of gh to stimulate endogenous hormones.
In vivo study	Ibutamoren mesylate (5 mg/kg/day) results in a statistically significant increases body weight gain and increases serum IGF-1 and GH levels in dogs. Ibutamoren mesylate results in no significant increase in CSF IGF-1 or GH levels on days 7 or 15 of the study. Pretreating mice with GH blocks activation of these neurons by Ibutamoren mesylate (50 μg, i.p.). In the knockout mice, both GH and octreotide fail to inhibit Ibutamoren mesylate activation of arcuate neurons. Chronic oral administration of MK-0677 is associated with significant increases in GH and IGF-I levels that are maintained for the duration of the treatment. The GH profile following MK-0677 administration consists of episodic increases above control. MK-0677 significantly increases peak GH concentrations after oral administration. MK-0677 is a potent GH secretagogue that induces an immediate, large, long lasting increase in GH levels when administered orally or i.v.